In the second quarter of 2024, we have signed new customers in North America and Asia, and we are continuing our investments in both image quality and data quality. Our cash flow remains stable, with a good cash position, and we are confident that the investments we are making now will drive long-term growth.

Q1 Highlights Participation in the European Congress of Radiology in Vienna meeting new potential customers and following up on previous discussions with potential customers. Celebrating 25 years of partnership with a customer, underscoring our commitment to long-lasting relationships and techological leadership. Rebuilding of the internal product development structure to enable faster and more frequent product […]

Q4 Highlights New advanced X-ray product Altumira™ Plus with scatter correction released Participation in world’s largest medical imaging conference, Radiological Society of North America (RSNA) Increasing interest from customers and OEMs in our products Strategic investments in Point of Care Ultrasound (POCUS), R&D and Quality Management Q4 Financial Data Record Q4 Net Sales of 33.2 […]

With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for growth. The strong performance is driven by a healthy core business supported by investments in growth initiatives such as the AI-based X-ray solution, Altumira. STOCKHOLM – October 26, 2023. […]